Intensity Therapeutics, Inc. (INTS) income statement
INTSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.64−0.03 (-1.12%)
Close on Nov 18, 2026Market cap $8.62MP/E –Yield –
Intensity Therapeutics, Inc. financial ratios
See a number that looks wrong?